Chris Markoch

Chris Markoch

InvestorPlace Contributor

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Fundamentals Matter, But SoFi Looks Like a Buy Anyway

By Chris Markoch, InvestorPlace Contributor

SOFI stock is down after posting a net loss. But for patient investors, the discounted price creates a buying opportunity. 

There’s Lots Happening, but Workhorse Group Is Noticeably Quiet These Days

By Chris Markoch, InvestorPlace Contributor

While other EV companies are hype machines, Workhorse Group management isn't saying much to keep investors interested in WKHS stock.

Hyliion Is Starting to Look So Bad, It’s Good

By Chris Markoch, InvestorPlace Contributor

HYLN stock is below $10 and is nearing oversold territory based on a key technical indicator. Now it's an appealing speculative stock.

Novavax Is Not a Sure Thing, But It’s Getting Closer

By Chris Markoch, InvestorPlace Contributor

By helping to address the international lack of Covid-19 vaccine access, NVAX stock may be a player in the Covid-19 vaccine race after all.  

Sundial Growers Needs a High Tide To Lift the Sinking Stock

By Chris Markoch, InvestorPlace Contributor

When the U.S. does become open for business, it’s likely to be a tide that lifts all cannabis stocks, including SNDL stock.  But is that reason enough to buy now?

Load More